BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11497201)

  • 1. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
    Lip GY; Edmunds E; Hee FL; Blann AD; Beevers DG
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):823-8. PubMed ID: 11497201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
    Gibbs CR; Blann AD; Watson RD; Lip GY
    Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
    Goldsmith IR; Blann AD; Patel RL; Lip GY
    Am J Cardiol; 2000 May; 85(10):1218-22. PubMed ID: 10802004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
    Lee KW; Blann AD; Lip GY
    Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
    Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
    Goldsmith IR; Blann AD; Patel RL; Lip GY
    Am J Cardiol; 2001 Jan; 87(1):107-10, A9. PubMed ID: 11137845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
    Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
    Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.
    Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ
    J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial.
    Li-Saw-Hee FL; Beevers DG; Lip GY
    Int J Cardiol; 2001 May; 78(3):241-6. PubMed ID: 11376827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
    Blann AD; Gurney D; Wadley M; Bareford D; Stonelake P; Lip GY
    Blood Coagul Fibrinolysis; 2001 Jan; 12(1):43-50. PubMed ID: 11229826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project.
    Lip GY; Blann AD; Farooqi IS; Zarifis J; Sagar G; Beevers DG
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):307-15. PubMed ID: 11460015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.
    Landray MJ; Wheeler DC; Lip GY; Newman DJ; Blann AD; McGlynn FJ; Ball S; Townend JN; Baigent C
    Am J Kidney Dis; 2004 Feb; 43(2):244-53. PubMed ID: 14750089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
    Lip PL; Blann AD; Hope-Ross M; Gibson JM; Lip GY
    Ophthalmology; 2001 Apr; 108(4):705-10. PubMed ID: 11297487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
    Lip GY; Lydakis C; Nuttall SL; Landray MJ; Watson RD; Blann AD
    J Intern Med; 2000 Oct; 248(4):316-8. PubMed ID: 11086642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.